HOME >> BIOLOGY >> NEWS
Study of flu patients reveals virus outsmarting key drug

MADISON - A drug envisioned as a front-line defense for the next flu pandemic might have a genetic Achilles' heel that results in a drug-resistant influenza virus capable of infecting new human hosts, according to a study published this week (Aug. 28) in the British medical journal The Lancet.

The study of Japanese children with influenza and treated with the antiviral drug oseltamivir was conducted by an international team of researchers led by virologist Yoshihiro Kawaoka of the University of Wisconsin-Madison and the University of Tokyo. Results of the study showed that nearly 20 percent of patients treated with the drug produced mutant drug-resistant viruses as soon as four days after treatment. Moreover, patients continued to shed significant amounts of infectious viral particles even after five days of treatment with the potent antiviral agent.

"The problem with this compound is that a single (genetic) mutation makes the virus resistant," says Kawaoka, an authority on influenza who holds an appointment at the UW-Madison School of Veterinary Medicine.

The finding is important because it provides evidence that influenza viruses can easily and quickly thwart one of the few lines of defense for a disease that claims many lives each year and that, in a pandemic, is among the world's most feared and deadly diseases.

"The importance of this work is that when a pandemic occurs with a new virus and this drug is extensively used, then we may be faced with the rapid appearance of resistant viruses," Kawaoka says.

At present, there are only two strategies for stemming the spread of influenza: vaccines and antiviral drugs. Vaccines use inactivated forms of a virus to ramp up the immune system and thwart infection. Antiviral drugs such as oseltamivir work by inhibiting key proteins on the surface of the virus, effectively locking them in their host cells and preventing the virus from escaping and infecting new cells and hosts.


'"/>

Contact: Yoshihiro Kawaoka
kawaokay@svm.vetmed.wisc.edu
University of Wisconsin-Madison
26-Aug-2004


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study in Science reveals recreational fishing takes big bite of ocean catch
7. Study suggests cell-cycle triggers might be cancer drug targets
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. Study links high carbohydrate diet to increased breast cancer risk
10. Study explains spatial orientation differences between sexes
11. Study suggests humans can speed evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/29/2020)... ... January 29, 2020 , ... ... vitro toxicology testing solutions, has announced a record earnings year for 2019. With ... showed more than a twenty percent increase in revenue and a thirty percent ...
(Date:1/28/2020)... ... January 28, 2020 , ... Blue Health Intelligence (BHI) ... cost of care, and limit the utilization of high-cost imaging and surgeries for ... San Antonio, Texas specializes in improving care delivery for MSK conditions. In an ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a ... level, today announced that the company will debut a novel new DNA isolation kit ... The new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit ...
Breaking Biology News(10 mins):
(Date:1/10/2020)... ... January 09, 2020 , ... A ... establishes benchmarks for the vendor qualification process, a critical element of clinical trial ... and complexity of the vendor qualification process creates delays in initiation in 7% ...
(Date:1/10/2020)... ... January 09, 2020 , ... GenScript ... inaugural GenScript Biotech Global Forum on Jan. 14 in San Francisco, coinciding with ... Gene Therapy and the Booming China Market," will feature gene and cell therapy ...
(Date:1/8/2020)... ... 08, 2020 , ... RMA of Connecticut , a ... their family, has announced that five of their Board-Certified reproductive endocrinologists have been ... renowned publishing company Castle Connolly has compiled the list of America’s ...
(Date:1/7/2020)... ... January 07, 2020 , ... Vuja De Sciences (“Vuja De”), ... recurrence, today announced the appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. ... Vuja De said, “We are delighted to welcome Chand and Lee as new directors. ...
Breaking Biology Technology:
Cached News: